Skip to main content
. Author manuscript; available in PMC: 2019 Dec 27.
Published in final edited form as: HPB (Oxford). 2018 Jan 20;20(5):470–476. doi: 10.1016/j.hpb.2017.11.010

Figure 2.

Figure 2.

Five-year overall survival for patients with resected Intrahepatic Cholangiocarcinoma with lymph node evaluation, stratified by lymph node status and, for N0 patients, further stratified based on the optimal threshold for the number of lymph nodes to examine based on maximal chi-square testing. Number at risk is included along the X axis.